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Background: The study and identification of new biomarkers for periodontal disease, such as microRNAs (miR-
NAs), may give us more information about the location and severity of the disease and will serve as a basis for 
treatment planning and disease-monitoring. miRNAs are a group of small RNAs which are involved in gene 
regulation by binding to their messenger RNA target (mRNA). In this pilot study, the procedure for purifying 
miRNAs from gingival crevicular fluid (GCF) was, for the first time, described. In addition, the concentration of 
miRNAs in GCF was analyzed and compared between patients with moderate or severe chronic periodontitis (CP) 
and healthy controls.
Material and Methods: GCF samples were collected from single-rooted teeth of patients with moderate or severe 
CP (n=9) and of healthy individuals (n=9). miRNAs were isolated from GCF using miRNeasy Serum/Plasma kit 
(Qiagen, CA. USA). Reverse transcription polymerase chain reaction (qRT-PCR) was used to determine the ex-
pression of a series of miRNAs candidates that are related to bone metabolism. The significance of differences in 
miRNA levels between both groups was determined using Mann-Whitney U test.  
Results: The results from this pilot study indicate that miRNAs can be isolated from GCF. Six different miRNAs 
were analyzed (miR-671, miR-122, miR-1306, miR-27a, miR-223, miR-1226), but only miR-1226 showed statically 
significant differences between the CP group and healthy controls (p<0.05). This miRNA was downregulated in 
patients with CP. 
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Introduction
Predominantly Gram-negative anaerobic or facultative 
bacteria within the subgingival biofilm are the primary 
etiological agents of periodontal diseases, nevertheless, 
the majority of periodontal tissue destruction is caused 
by an inappropriate host response to those microorgan-
isms and their products (1).
GCF is a transudate that is released into the gingival 
sulcus of the teeth. It is mainly composed of polymor-
phonuclear leukocytes (PMNs), serum proteins, bac-
teria, tissue breakdown products, enzymes, antibodies 
and numerous inflammatory mediators and nucleic ac-
ids. GCF collection is a non-invasive and simple pro-
cedure and is especially useful for identifying people 
at risk for initiation or progression of periodontitis and 
for monitoring the response to periodontal therapy (2). 
Epigenetic regulation can exert a narrow control over 
the expression of key genes which underlies the patho-
physiology of periodontal disease (i.e. inflammation, 
bone resorption, etc.) (3). There is evidence suggesting 
that chronic inflammation and bacterial infection alters 
DNA methylation of genes codifying for pro-inflamma-
tory (i.e.IL-1, IL-6, IFN-γ, TNF-α) and anti-inflamma-
tory cytokines (i.e., IL4, IL-10, IL-11, etc.) (4). Further-
more, Zhang et al. observed a hypomethylation of the 
inflammatory gene IFN-γ (5) and also a hypermethyl-
ation of TNF-α (6). In the same study, they observed in 
inflamed gingival tissues from patients with CP, a de-
creased expression of COX-2 due to a hypermethylation 
of its promoter, results that were also demonstrated by 
Loo et al. (7). Besides DNA methylation, histone post-
translational modifications (HPTMs) also regulate epi-
genetic mechanisms. In fact, histone deacetylase inhibi-
tors (HDACi), such as 1179.4b and MS-275, have shown 
promising therapeutic properties against bone loss pro-
duced on Porphyromonas gingivalis-inoculated mice 
(8), suggesting that HPTMs regulate the expression of 
key genes involved in periodontal disease.
Besides the above-mentioned epigenetic mechanisms, 
non-coding RNAs (i.e. long non-coding RNAs and 
miRNAs) also participate in the epigenetic control of 
gene expression. However, as far as we know, epigen-
etic regulation by miRNAs has not yet been studied in 
periodontal disease using GCF.
miRNAs are a new and promising potential biomarker 
for diagnosis and prognosis of many diseases (9) be-
cause they act as signaling molecules and participate 
in many biological processes, such as cellular develop-
ment, differentiation, and apoptosis. The high stability 
of circulating miRNAs in a RNase-rich environment 
such as the bloodstream (10), make these biomolecules 
an optimal source for the identification of candidate 
biomarkers. In fact, miRNAs have demonstrated their 
value as biomarkers in a wide variety of human diseases 
(9).
miRNAs are a large family of short non-coding RNAs 
(17-25 nucleotides) which are involved in gene regula-
tion by binding to their messenger RNA target (mRNA). 
In the periodontum, miRNAs may play key roles in 
periodontal tissue development and homeostasis and 
during the loss of periodontal tissue integrity as a result 
of periodontal disease (11). In addition, they have been 
proposed as important contributors to bone morphogen-
esis and osteoclastogenesis (OsteomiRs) (12), making 
them interesting biomolecules for the study of molecu-
lar causes of periodontal diseases.
These findings prompted us to investigate miRNA 
extraction and quantification from an easily collected 
transudate, the GCF. In addition, the concentration of 
miRNAs that have been related to bone metabolism was 
analyzed and compared between patients with moderate 
or severe chronic periodontitis and healthy controls.
 
Material and Methods
-Patient and site selection
Nine healthy individuals (four males and five females, 
aged 25 to 60 years) and nine patients with moderate 
or severe CP (three males and six females, aged 36 to 
61 years) who were referred to the Department of Peri-
odontology at the Faculty of Medicine and Dentistry, 
University of Valencia, Valencia, Spain, participated in 
this pilot study. The study was conducted from Janu-
ary to July 2016. Every patient and healthy individual 
enrolled in the investigation provided written informed 
consent. In addition, the research related to human use 
has been complied with all the relevant national regula-
tions, institutional policies and in accordance the tenets 
of the Helsinki Declaration, and has been approved by 
the Experimental Research Ethics Committee of the 
University of Valencia.
For each individual, pocket depth (PD), recession, clini-
cal attachment level (CAL) and bleeding on probing 
(BP) values were measured with a periodontal probe. 
A single calibrated examiner assessed these clinical 
Conclusions: Within the limitations of the present study, it may be concluded that miR-1226 can be a promising bio-
marker for periodontal disease, adding relevant information to common clinical parameters used for diagnosis and 
prognosis of periodontitis.
Key words: Small interfering RNA, biomarkers, periodontal diseases, reverse transcriptase polymerase chain reac-
tion.
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parameters. Healthy individuals (control group) did not 
present any sign or symptom compatible with periodon-
tal disease (PD<3mm, CAL<3mm and no radiographic 
evidence of alveolar bone breakdown). On the other 
hand, the test group consisted of patients with moderate 
or severe CP (based on the Classification of Periodontal 
Diseases and Conditions of Armitage, 1999) (13) with at 
least one single-rooted tooth with CAL≥6mm and prob-
ing depth ≥5mm. Exclusion criteria included: 1) smok-
ing; 2) patients diagnosed with chronic periodontitis but 
without one single-rooted tooth with CAL≥6mm and 
probing depth ≥5mm.; 3) patients diagnosed with aggres-
sive periodontitis; 4) presence of any systemic disease or 
use of drugs that affect bone metabolism (osteoporosis, 
arthritis, hormonal therapy, bisphosphonates, anti-in-
flammatories, immunosuppressants) 5) use of antibiot-
ics, anti-inflammatories or contraceptives within the last 
three months; 6) primary or secondary occlusal trauma 
in teeth included for the study; 7) patients who had re-
ceived periodontal treatment within the last 6 months; 8) 
patients undergoing orthodontic treatment; 9) pregnant 
or lactating women; 10) patients with a periapical or peri-
odontal abscess around the tooth used for the study. 
In both groups, a GCF sample was taken from a single-
rooted tooth (in test group, from teeth with CAL≥6mm), 
due to its easy access and to avoid errors associated to 
GCF sample collection.
-GCF collection
Before placing the absorbing paper strip within the sul-
cus, supragingival plaque was removed, and relative 
isolation was performed using cotton rolls and aspira-
tion to prevent saliva contamination. Subsequently, the 
filter paper strip Periopaper® (Oraflow, New York, NY, 
USA) was placed in the gingival sulcus until resistance 
was felt and left in this position for 30 seconds (14). If 
the paper was bloodstained or contaminated with saliva 
or detritus, the sample was excluded and the procedure 
was repeated. Finally, the filter paper strip was intro-
duced in a sterile Eppendorf tube and stored at -80ºC.    
-RNA extraction and quantification from GCF 
Periopapers® were incubated in Phosphate-saline buf-
fer (PBF) solution pH 7 for 30 min at room temperature. 
In order to recover all the solution contained in the strip, 
each sample was centrifuged at 500 rpm for 10 minutes 
and stored again at -80ºC until RNA extraction. Cell-
free total RNA (including miRNAs) was isolated from 
200 uL of PBS solution containing the biological ma-
terial from the Periopaper® using miRNeasy Serum/
Plasma kit (Qiagen, CA. USA). RNA was eluted with 
25 µL of RNAse-free water. Cell-free total RNA (in-
cluding miRNAs) concentration was quantified using 
NanoDrop ND 2000 UV-spectrophotometer (Thermo 
Scientific, Wilmington, DE, USA) and the sample qual-
ity was measured with the Small RNA Assay, Agilent 
2100 Bioanalyzer (Agilent Technologies).
-miRNAs signature prediction for CP diagnosis
In order to identify which miRNAs would be interesting 
to study, a literature review was conducted using Pubmed 
database, on the relevant biological pathways related to 
bone metabolism and periodontitis. Subsequently, from 
the selected manuscripts, key pathways represented in 
KEGG (Kyoto Encyclopedia of Genes and Genomes) 
were selected. Then, mirPath v3 KEGG Reverse Search 
(selecting the method TarBase v7.0) was used to identify 
miRNAs that target key genes of those pathways (15). 
Furthermore, we also included blood-circulating miR-
NAs which had been related to bone metabolism regula-
tion, based on a previous study carried out on patients 
with idiopathic scoliosis (16). 
We finally chose those miRNAs which were found at 
least 5 times in each KEGG pathway and that coincided 
with García-Giménez’s study (16). The selected miR-
NAs are shown in Table 1.
-Quantitation of miRNAs by RT-PCR 
Reverse transcription (RT) reactions were performed 
using TaqMan miRNA Reverse Transcription kit, 
miRNA-specific stem-loop primers (Part No. 4366597, 
Applied Biosystems, Inc) and 100 ng of input cell-free 
RNA in 15 µL RT reaction. Real-time PCR reactions 
were performed in triplicate, in scaled-down 10 µL re-
action volumes using 5 µL TaqMan 2x Universal PCR 
Master Mix with No UNG, 0.5 µL TaqMan Small RNA 
assay (20x), hsa-miR-27a-5p (002445), hsa-miR-223-5p 
(002098), hsa-miR-671-5p (197646_mat), has-miR-122-
5p (002245), hsa-miR-1226-5p (002758), hsa-miR-1306-
3p (241056_mat) and hsa-miR-16-5p (000391) as endoge-
Table 1: Selected miRNAs as biomarkers for periodontal disease.
miRNA name Mature sequence Accesion 
has-miR-671-5p aggaagcccuggaggggcuggag MIMAT0003880 
has-miR-1306-3p acguuggcucugguggug MIMAT0005950 
has-miR-1226-5p gugagggcaugcaggccuggaugggg MIMAT0005576 
has-miR-27a-5p agggcuuagcugcuugugagca MIMAT0004501 
has-miR-223-5p cguguauuugacaagcugaguu MIMAT0004570 
has-miR-122-5p uggagugugacaaugguguuug MIMAT0000421 
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nous control gene (Table 1), 3.5 µL of nuclease free water 
and 1 µL of RT product. Real-time PCR was carried out 
on Applied BioSystems 7900HT thermocycler (Applied 
Biosystems. Inc, CA; USA) programmed as follows: 
50ºC for 2 minutes, 95 ºC for 10 minutes followed by 45 
cycles of 95ºC for 15 seconds and 60ºC for 1 minute. One 
of the most stable counting reads miRNAs and previous-
ly used as endogenous control (17), miRNA hsa-miR-16-
5p (000391), was used to normalize the expression data 
using the delta-delta CT method (2-ΔΔCT).
-miRNA target prediction and over-representation analysis
There are a large number of potential mRNA target sites 
for any given miRNA. The computational approach to 
predict miRNAs targets facilitates the selection pro-
cess of specific targets. For our study, DIANA-microT 
web server v5.0 (18) was used, suited to identify those 
genes whose expression appeared to be controlled by 
the statistically significant miRNAs. For this purpose 
we used the following default parameters: DIANA Tar-
Base v.7.0, with a p-value threshold of 0.001, and microT 
with a threshold of 0.8. To reduce false positive miRNA 
targets, we applied a false discovery rate (FDR) correc-
tion. The algorithm utilized in this analysis consisted on 
one-tailed Fisher’s exact test.
-Statistical analysis
The mean was taken as the measurement of the main 
tendency, and the standard deviation was taken as the 
dispersion measurement for the statistical analysis of 
results. Mann-Whitney U analysis was performed to 
compare both groups of patients and controls. A p-value 
of <0.05 was considered statistically significant.
Results
There were 6 (66.7%) females and 3 (33.3%) males in the 
test group, and 5 (55.6%) females and 4 (44.4%) males in 
the healthy control group. The mean age for the chronic 
periodontitis group was 50.44±8.09 (36-61) years old 
and 33.33±12.05 (25-60) years old for the healthy group. 
The mean values of the clinical attachment level of the 
single-rooted teeth were 7.00±1mm for the test group and 
2.00±0.71mm for the control group. These demographic 
and clinical parameters are summarized in table 2.
Chronic periodontitis (n=9) Control (n=9)
Mean Standard 
deviation
CI 95% Mean Standard deviation CI 95%
Age (years) 50.44 8.09 44.22-56.67 33.33 12.05 24.07-42.60
Gender: female % 66.7% 55.6%
Gender: male % 33.3% 44.4%
Pocket depth (mm) 5.89 0.60 5.43-6.35 2.00 0.71 1.46-2.54
Clinical attachment loss 
(mm)
7.00 1.00 6.23-7.77 2.00 0.71 1.46-2.54
Table 2: Demographic and clinical characteristics of test and control group.
-miRNAs can be isolated from GCF
From each sample, 10 ng of total RNA was analyzed us-
ing the Agilent Small RNA Assay. This assay shows the 
distribution of small RNA fragments (including miR-
NAs) ranging in size from 6 to 150 nt, thus allowing the 
detection of different RNA families. 
This investigation shows that smallRNAs can be iso-
lated from GCF. The electrophoretic profile of RNA 
from GCF showed different bands probably due to the 
presence of different RNA families: miRNA molecules 
(10 to 40 nt, mainly concentrated at 20 nt), small RNA 
fragments (between 6 to 150 nt), snoRNA fragments 
(60-150 nt) and pre-miRNAs (90-150 nt). Different pat-
terns in elecropherograms from 6 randomized samples 
obtained from patients (samples 1, 2 and 3) and from 
controls (samples 4, 5, and 6) were observed, indicat-
ing differences in smallRNA distribution and miRNA 
enrichment percentage in the whole recovered sample 
(Fig. 1).
-Selected miRNAs for the study
The following six miRNAs were found at least 5 times 
in each KEGG pathway and coincided with García-Gi-
ménez’s study(16), and thus were selected for the study: 
miR-671, miR-122, miR-1306, miR-223, miR-27a and 
miR-1226.
-miR-1226-5p identifies patients with periodontal dis-
ease
Reverse transcription polymerase chain reaction (RT-
PCR) was used to determine the relative expression lev-
els of the six representative miRNAs selected for the 
study (Table 3).
miR-671 and miR-122 were not detected in GFC, un-
like the other 4 miRNAs studied. In addition, differ-
ences in expression levels of miR-1306 and miR-223 
between patients and controls were not found (Fig. 2 
and Table 3). On the other hand, regarding to miR-27a, 
a tendency to be downregulated in patients with CP was 
observed, nevertheless these differences were not sta-
tistically significant. However, miR-1226-5p was found 
to be 15.8-fold downregulated (p<0.05) in patients with 
periodontal disease suggesting that this miRNA could 
be a feasible biomarker of the disease (Fig. 2). 
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Fig. 1: Electropherograms of smallRNAs isolated from GCF of 3 randomized patients and 3 randomized controls. Elecropherograms showed 
differences among them in smallRNA distribution and miRNA enrichment percentage.
Healthy subjects Patients with CP P-value
mir-122 n/a n/a n/a
mir-1226-5p 1,376±0,993 0,390±0,334 0,0004
mir-1306 1,273±0,939 0,872±0,445 0,3282
mir-27a 1,124±0,505 0,925±0,302 0,1963
mir-223 1,059±0,339 0,997±0,358 0,3757
mir-671 n/a n/a n/a
Table 3: Relative quantification of miRNAs by real-time RT-PCR. Mean and standard deviation 
(mean±sd) of miRNAs relative expression (2-ΔΔCT) in healthy subjects and patients with CP. P-value 
obtained comparing miRNAs relative expression of healthy subjects and patients with CP using U of 
Mann-Whitney analysis. n/a: not data.
Fig. 2: Relative expression levels of miRNAs detected in GCF of patients with CP compared to healthy 
subjects.  Black bars correspond to control group and grey bars to test group. U of Mann-Whitney analysis 
was applied. p < 0.05 was considered to be statistically significant. miR-1226 was significantly downregu-
lated in test group compared to controls. 
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-miRNA targets analysis 
miR-1226-5p was the only epigenetic biomarker that 
showed statistically significant differences between 
healthy subjects compared to patients in regards to rela-
tive expression levels. Therefore, we only searched for 
target genes whose expression was controlled by this 
miRNA. In this regard, the proteins calreticulin and 
mucin 1 were identified as target genes of this miRNA, 
by DIANA-microT web server v5.0.
Discussion
The identification of new epigenetic biomarkers may 
clearly contribute to improve clinical diagnosis and 
prognosis of many human diseases, such as periodon-
titis. 
miRNAs have been considered promising biomarkers 
(9) due to its high stability in different biofluids com-
monly used in analytical assays (9,10). 
To our knowledge, this is the first work that have report-
ed the possibility of detecting and measuring by qRT-
PCR techniques, miRNAs in GCF, in order to identify 
periodontitis biomarkers. Our first result indicated that 
smallRNAs can be isolated from GCF using similar 
procedures to those used for other biological fluids such 
as plasma. Because different elecropherogram patterns 
were found in the same group (patients or controls), we 
suggest that differences in smallRNA profile are not 
due to the pathological process itself, but to the differ-
ences in small RNA biological profiles of each indi-
vidual, changes in the ability of Periopaper® to absorb 
smallRNA species, and/or different recovery efficien-
cies of smallRNA from Periopaper® during smallRNA 
purification procedure.
In order to identify miRNAs associated to periodontal 
disease, we measured 6 miRNAs related to bone me-
tabolism, some of them (i.e. miR-27a and miR-223) also 
known as osteomiRs (12). In our study, miR-1226 was 
the only miRNA which was significantly downregulat-
ed in patients with CP. 
In addition, we used in silico studies (DIANA-microT 
web server v5.0) to identify miR-1226 targets such as 
CALR and MUC1. Particularly, this miRNA targets 
the 3’ UTR of CALR messenger so its function will be 
blocked (19). CALR is a multifunctional protein whose 
main functions are Ca2+ storage and gene expression 
regulation when is located in the nucleus. CALR ex-
pression can affect retinoic acid-dependent differen-
tiation and inhibit vitamin D-induced stimulation of 
osteocalcin expression, so it can inhibit mineralization 
(19). Therefore, downregulation of miR-1226 may pro-
duce CALR overexpression contributing to bone miner-
alization decrease.
On the other hand, MUC1 acts as a tumor suppressor as 
it prevents aberrant upregulation of genes related to cell 
acquisition of malignant phenotype (20). MUC1 over-
expression gives rise to two protein subunits that can 
interact with members of the receptor tyrosine kinase 
family and induce cell transformation (21). On the other 
hand, MUC1 can also control Wnt/β-catenin pathway. 
MUC1-C72 amino acid cytoplasmic domain (MUC1-
CD) interacts with different effectors, promoting cell 
survival and proliferation, apoptosis and inflammation 
in different cells, including osteoblasts. For example, 
MUC1 blocks GSK3B phosphorylating β-catenin, 
therefore avoids β-catenin degradation (21). This is very 
important because Wnt signaling plays an essential role 
in bone metabolism by controlling the stem cells differ-
entiation into mature osteoblasts or osteoclasts (22,23). 
MUC1 can also be involved protein p53 transcription 
regulation after genotoxic stress, inhibiting p53-me-
diated apoptosis and promoting cell cycle arrest (24), 
therefore MUC1 can block cell cycle and proliferation 
in osteoblasts cells. 
In addition, MUC1 also activates IκB (Kinase beta 
complex) (25) therefore releasing IκBα activating NF-
κB p65/RelA (26), so contributes to the activation of 
canonical NF-κB pathway (27). This NF-κB regulation 
could be of special interest not only for its role in os-
teoclast formation in presence of receptor activator of 
NF-κB ligand (RANKL) and TNF, but also because it 
has been recently described the essential dual role of 
NF-κB activating or inhibiting cytokine-mediated os-
teoclast formation by regulating the key factor NFATc1 
expression (27). 
Furthermore, we reviewed the literature in order to 
identify other possible roles or mechanisms in which 
miR-1226 participates in regulating bone metabolism. 
Interestingly, we found out that miR-1226 was one of 
the miRNAs able to differentiate acute from chronic 
disease cases of Brucellosis, being this miRNA specifi-
cally downregulated in chronic cases (28). In brucello-
sis disease, a serious loss of bone occurs (28). One of the 
reasons is the damage that Brucella produces on osteo-
blast function. Furthermore, Brucella infection induces 
an increase in the number of osteoclasts, reduces os-
teoblast differentiation and contributes to its apoptosis 
(29), therefore resulting in bone resorption.
In the present study, we described the procedure for pu-
rifying miRNAs from GCF. In addition, this pilot study 
shows that miR-1126 can provide clinicians another tool 
to identify susceptible patients and may add relevant in-
formation to common clinical parameters used for diag-
nosis and prognosis of periodontitis. These preliminary 
results encourage further investigation with a larger 
sample size to determine the effectiveness of miR-1226 
as a valuable biomarker for periodontitis. 
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